Skip to main
PRE

PRE Stock Forecast & Price Target

PRE Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Prenetics Global is well-positioned in a rapidly growing subset of the global dietary supplements market, with strong clinical validation, an attractive value proposition, and a successful track record of customer acquisition, retention, and monetization. The company's expanding product portfolio, growing roster of influential brand ambassadors, and strategic marketing initiatives make it a high-growth potential company with a positive revenue CAGR outlook. Additionally, Prenetics has a strong balance sheet and experienced leadership, providing a solid foundation for sustainable growth and potential profitability.

Bears say

Prenetics Global is experiencing strong financial improvement due to the introduction and expansion of quarterly subscription plans, resulting in higher average order value, improved customer subscription rates, higher revenue, and improved LTV/CAC. This shift to quarterly subscriptions is also leading to lower fulfillment costs and more predictable renewals, creating a positive impact on the company's financial health and reducing its working capital demands.

PRE has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prenetics Global Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prenetics Global Ltd (PRE) Forecast

Analysts have given PRE a Strong Buy based on their latest research and market trends.

According to 5 analysts, PRE has a Strong Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prenetics Global Ltd (PRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.